Delivery Order SPE2DR25D1017-SPE2DR26F9CLP
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,052.80 on December 11, 2025, for the supply of Spikevax 2025-26 vaccine for individuals 12 years and older in 0.5 mL syringes. The contract is firm fixed price with no set-aside designation and is scheduled for completion by January 5, 2026. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,431.78 on June 18, 2025, for the supply of Spikevax 2024-25 vaccine (12 years and older) in 0.5 mL syringes. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of July 11, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Spikevax 2025-26 vaccine (12 years and up) in 0.5 mL syringes, valued at $14,201.30. This is a firm fixed price delivery order with no set-aside designation, reflecting competitive procurement practices. The contract is scheduled for completion by December 1, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 18, 2025, for the supply of Spikevax 2025-26 vaccine (12 years and up) in 0.5 mL syringes, valued at $1,052.80 with a completion date of January 12, 2026. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 25, 2025, for the supply of Spikevax 2024-25 vaccine (12 years and up) in 0.5mL syringes, with a contract ceiling value of $7,158.90 and a completion date of July 17, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 27, 2025, for the supply of Spikevax 2025-26 vaccine (12 years and older) in 0.5 mL syringes, valued at $7,227.30. This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 20, 2025, with performance based at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child delivery order under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,052.80 to AmerisourceBergen Drug Corp for Spikevax 2025-26 vaccine (12 years and up) in 0.5 mL syringes. This competitively awarded, firm fixed-price contract was executed on December 8, 2025, with an ultimate completion date of December 30, 2025. The pharmaceutical product will be supplied from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a $2,718.60 delivery order to AmerisourceBergen Drug Corp for SPIKEVAX 2025-26 vaccine doses (12 years and up) on November 6, 2025, with completion scheduled for December 1, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The vaccine...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for SPIKEVAX 2025-26 vaccine doses (12 years and up) in 0.5 mL syringes, with a ceiling value of $2,736.13. This firm fixed-price delivery order, issued on December 15, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 through December 2026. The work is scheduled for completion by January...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Spikevax 2025-26 vaccine (12 years and up) in 0.5ml syringes with a ceiling value of $1,087.46. The contract employs firm fixed-price pricing, with an ultimate completion date of December 3, 2025, and was awarded on November 10, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside...
- SPE2DR25D1017Indefinite Delivery Contract
- SPE2DR25D1017-SPE2DR26F9CLPDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 2, 2026, for the supply of Spikevax 2025-26 vaccine (12 years and older) in 0.5 mL syringes, with a contract ceiling value of $2,686.17 and an ultimate completion date of January 26, 2026. This non-set-aside, competitively awarded delivery order utilizes firm fixed pricing and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999 global pharmaceutical support vehicle valued through December 2026 that enables the company to supply pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains an extensive portfolio of federal medical supply contracts predominantly with the Defense Logistics Agency and its Medical Supply Chain. The company's federal contracting demonstrates proven capability to fulfill diverse pharmaceutical procurement requirements, including vaccines, specialty medications, brand-name and generic drugs, and related medical supplies across multiple therapeutic domains. This award supports critical vaccine distribution needs for the Department of Defense and affiliated healthcare systems serving military personnel and beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 1/1/26 |